Stephenson Pamela
Insider CIK 1767650 · ALBO Chief Commercial Officer · ZYNE Director · IRON Chief Commercial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IRON Disc Medicine, Inc. | S Sale | 2026-02-17 | 2026-02-17 | 5,531 | $62.86 | $347.7K | 80,998 | SEC↗ |
| IRON Disc Medicine, Inc. | A Award deriv | 2026-02-10 | 2026-02-11 | 25,500 | — | $0 | 25,500 | SEC↗ |
| IRON Disc Medicine, Inc. | A Award | 2026-02-10 | 2026-02-11 | 17,000 | — | $0 | 86,529 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-02-18 | 2025-02-20 | 3,137 | $54.58 | $171.2K | 69,529 | SEC↗ |
| IRON Disc Medicine, Inc. | A Award deriv | 2025-02-10 | 2025-02-12 | 36,000 | — | $0 | 36,000 | SEC↗ |
| IRON Disc Medicine, Inc. | A Award | 2025-02-10 | 2025-02-12 | 36,000 | — | $0 | 72,666 | SEC↗ |
| IRON Disc Medicine, Inc. | A Award deriv | 2024-02-26 | 2024-02-27 | 55,000 | — | $0 | 55,000 | SEC↗ |
| IRON Disc Medicine, Inc. | A Award | 2024-02-26 | 2024-02-27 | 36,666 | — | $0 | 36,666 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | D To issuer deriv | 2023-10-10 | 2023-10-11 | 34,663 | — | $0 | 0 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | D To issuer deriv | 2023-10-10 | 2023-10-11 | 71,736 | — | $0 | 0 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | U Tender | 2023-10-10 | 2023-10-11 | 27,954 | — | $0 | 47,824 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | U Tender | 2023-10-10 | 2023-10-11 | 47,824 | — | $0 | 0 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | S Sale | 2023-06-14 | 2023-06-15 | 115 | $0.35 | $40 | 75,778 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2023-06-13 | 2023-06-15 | 71,736 | — | $0 | 71,736 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award | 2023-06-13 | 2023-06-15 | 47,824 | — | $0 | 75,893 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | D To issuer deriv | 2023-03-02 | 2023-03-02 | 23,700 | — | $0 | 0 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | D To issuer deriv | 2023-03-02 | 2023-03-02 | 31,500 | — | $0 | 0 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | D To issuer deriv | 2023-03-02 | 2023-03-02 | 37,500 | — | $0 | 0 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | D To issuer deriv | 2023-03-02 | 2023-03-02 | 75,513 | — | $0 | 0 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | U Tender | 2023-03-02 | 2023-03-02 | 22,242 | — | $0 | 0 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2023-01-23 | 2023-01-23 | 102 | $43.80 | $4.5K | 42,755 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2023-01-19 | 2023-01-20 | 1,774 | $43.90 | $77.9K | 42,857 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award | 2023-01-19 | 2023-01-25 | 55,000 | — | $0 | 97,755 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award | 2023-01-19 | 2023-01-27 | 55,000 | — | $0 | 97,755 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2022-12-27 | 2023-01-09 | 469 | $19.06 | $8.9K | 44,631 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2022-12-27 | 2022-12-27 | 469 | $19.06 | $8.9K | 45,178 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2022-10-24 | 2022-10-25 | 104 | $19.58 | $2.0K | 45,647 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2022-09-26 | 2022-09-27 | 445 | $19.40 | $8.6K | 45,751 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2022-07-22 | 2023-01-09 | 106 | $24.67 | $2.6K | 45,649 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2022-07-22 | 2022-07-25 | 106 | $24.67 | $2.6K | 46,196 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2022-06-27 | 2022-06-28 | 461 | $19.47 | $9.0K | 45,755 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2022-06-14 | 2022-06-16 | 34,663 | — | $0 | 34,663 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award | 2022-06-14 | 2022-06-16 | 23,109 | — | $0 | 28,109 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | S Sale | 2022-06-14 | 2022-06-16 | 40 | $1.01 | $40 | 28,069 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2022-04-22 | 2022-04-25 | 103 | $32.92 | $3.4K | 46,216 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2022-03-28 | 2022-03-29 | 454 | $30.53 | $13.9K | 46,319 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2022-01-24 | 2022-01-25 | 416 | $24.88 | $10.4K | 46,773 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award | 2022-01-18 | 2022-01-20 | 21,600 | — | $0 | 47,189 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2021-12-27 | 2021-12-27 | 474 | $23.92 | $11.3K | 25,589 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2021-09-27 | 2021-09-28 | 451 | $32.05 | $14.5K | 26,063 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2021-08-03 | 2021-08-05 | 7,500 | — | $0 | 7,500 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award | 2021-08-03 | 2021-08-05 | 5,000 | — | $0 | 5,000 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2021-06-25 | 2021-06-28 | 471 | $36.01 | $17.0K | 26,514 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2021-03-29 | 2021-03-31 | 422 | $34.02 | $14.4K | 26,985 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award deriv | 2021-01-21 | 2021-01-25 | 23,700 | — | $0 | 23,700 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award | 2021-01-21 | 2021-01-25 | 5,500 | — | $0 | 27,407 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2020-12-28 | 2020-12-29 | 460 | $39.07 | $18.0K | 21,907 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2020-09-25 | 2020-09-25 | 451 | $33.20 | $15.0K | 22,367 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2020-06-25 | 2020-06-26 | 397 | $30.79 | $12.2K | 22,818 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2020-06-10 | 2020-06-11 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2020-03-25 | 2020-03-25 | 1,785 | $17.60 | $31.4K | 23,215 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award deriv | 2020-01-21 | 2020-01-23 | 31,500 | — | $0 | 31,500 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2019-06-11 | 2019-06-13 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award deriv | 2019-03-25 | 2019-03-27 | 37,500 | — | $0 | 37,500 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award | 2019-03-25 | 2019-03-27 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2019-02-19 | 2019-02-20 | 35,000 | — | $0 | 35,000 | SEC↗ |